Skip to main content
Livermore
Livermore
ZHEN

Wave Life Sciences, Inc.

WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001631574

In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

Superinvestors holding WVE, Q2 2026

2 superinvestors report holding Wave Life Sciences, Inc. on Form 13F, worth $60.7M in total. Weight is Wave Life Sciences, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding WVE in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
Maverick CapitalLee Ainslie0.5%10,278,115$59.7MAdded+1.1%
Duquesne Family OfficeStanley Druckenmiller<0.1%173,000$1.00MUnchanged

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of WVE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+1.1%)

  2. Q1 2026

    2 superinvestors holding at quarter end

    Added
    Maverick Capital (+9.5%)

  3. Q4 2025

    2 superinvestors holding at quarter end

    New
    Duquesne Family Office
    Added
    Maverick Capital (+10.6%)

  4. Q3 2025

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (+1.6%)

  5. Q1 2025

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (0.0%)

  6. Q4 2024

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−17.8%)

  7. Q3 2024

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (+31.0%)

  8. Q2 2024

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−0.2%)

  9. Q1 2024

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−9.0%)

  10. Q4 2023

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (+28.1%)

  11. Q3 2023

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (0.0%)

  12. Q1 2023

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−7.1%)

  13. Q4 2022

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−9.1%)

  14. Q2 2022

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (+39.5%)

  15. Q4 2021

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (+75.2%)

  16. Q3 2021

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (+3.4%)

  17. Q2 2021

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (+0.2%)